Pharmaceutical for subcutaneous or intramuscular administration

Details Pharmaceutical for subcutaneous or intramuscular administration Pharmaceutical for subcutaneous or intramuscular administration

1995-06-07

1997-11-25

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 8, 514 21, 530324, A61K 3800, A61K 3816

Patent

active

056913125

ABSTRACT:
Liquid pharmaceuticals for subcutaneous (sc) or intramuscular (im) administration containing a polypeptide and at least one amino acid, a process for the preparation of such a pharmaceutical and the use of an amino acid, which is suitable for sc or im administration, in a solution of a polypeptide are described.

REFERENCES:
patent: 4327086 (1982-04-01), Fukushima et al.
patent: 4508709 (1985-04-01), Amphlett et al.
patent: 4568544 (1986-02-01), Hasegawa et al.
patent: 4806524 (1989-02-01), Kawaguchi et al.
patent: 4857320 (1989-08-01), Wittwer
patent: 4992419 (1991-02-01), Woog et al.
patent: 5068106 (1991-11-01), Paques et al.
patent: 5091363 (1992-02-01), Heimburger et al.
patent: 5097019 (1992-03-01), Lobermann et al.
patent: 5358708 (1994-10-01), Patel
patent: 5503827 (1996-04-01), Woog et al.
Yamahira et al. CA vol. 92 No. 13543Q (1980).

Affiliated with

Also associated with

Rating

Pharmaceutical for subcutaneous or intramuscular administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical for subcutaneous or intramuscular administration , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical for subcutaneous or intramuscular administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2107162